HIGHFDA DEVICE

Beckman Coulter AU5800 Chemistry Analyzer Recall for 47 Units Over Calibration Delay Issues (2026)

Beckman Coulter Mishima K.K. recalled 47 AU5800 chemistry analyzers sold nationwide in the United States after a software delay can cause calibration and reagent databases to fail to open. The issue occurs when a calibration monitor using Microsoft SQL Server 2022 Express remains open for more than 15 minutes, potentially halting analysis. Healthcare facilities should stop using the devices and (a

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
January 30, 2026
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
January 30, 2026
Hazard Level
HIGH
Brand
Beckman Coulter
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Beckman Coulter
Product type
Chemistry Analyzer
Model numbers
B96697, B96698, B23279, B23280, B23281
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 30, 2026

  2. Reported by FDA DEVICE

    March 18, 2026

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

A delay in results may occur. When clinical chemistry analyzer calibration monitor with PC installed with Microsoft SQL Server 2022 Express is open beyond15 minutes may lead to: Reagent Blank and calibration databases not opening errors: CAL History DB Open Error.., RB History DB Open Error..; system will stop analyzing, firm service must visit to apply software solution; may lead to delay in diagnosis and/or patient treatment

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Beckman Coulter Mishima K.K. or your healthcare provider for instructions. Notification method: Letter

About This Product

The AU5800 is a high-throughput chemistry analyzer used in clinical laboratories to perform multiple assays. It is often deployed in hospital and reference labs for timely patient diagnostics.

Why This Is Dangerous

If the calibration monitor remains open for more than 15 minutes, databases may fail to open, causing a delay in results and potential interruption of diagnostic workflows.

Industry Context

This recall is not described as part of a broader industry pattern in the provided information.

Real-World Impact

Delays in test results can impact diagnosis and patient treatment timelines, particularly in high-volume labs.

Practical Guidance

How to identify if yours is affected

  1. Check if your AU5800 units have references B96697, B96698, B23279, B23280, B23281
  2. Review recall letters from Beckman Coulter
  3. Verify SQL Server 2022 Express is not left open for extended periods on calibration PCs

Where to find product info

Recall letters and device identifiers are available via Beckman Coulter or the FDA recall page referenced in the data.

What timeline to expect

Remedy processing may take weeks; exact timelines will be provided by Beckman Coulter after service scheduling.

If the manufacturer is unresponsive

  • Document all communications with Beckman Coulter
  • Escalate to hospital risk management or regional medical device supervisory body if vendor is unresponsive
  • Consider consulting with the FDA for guidance on unresponsive recalls

How to prevent similar issues

  • Verify calibration software updates are installed as directed by Beckman Coulter
  • Monitor calibration PC usage to ensure no long open sessions
  • Maintain an online log of device status and recall communications

Documentation advice

Keep recall letters, model numbers, serial numbers, purchase records, and service communications in a dedicated file for compliance and audit purposes

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: CHEMISTRY ANALYZER AU5800 Reference numbers: B96697, B96698, B23279, B23280, B23281 Sold in: United States nationwide Recall date: 2026-01-30 Manufacturer: Beckman Coulter Mishima K.K. Quantity: 47 units Price: Unknown Status: Active Notes: Distribution includes multiple states nationwide.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Calibration delay could halt patient testing
  • Software remedy required by service professionals
  • FDA and CPSR-regulated medical device recall

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
B96697
B96698
B23279
B23280
B23281
Affected States
ALL
Report Date
March 18, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Beckman Coulter Recalls Diluent Due to Elevated Platelet Counts

Beckman Coulter recalled 76,098 units of COULTER DxH Diluent on November 10, 2025. The recall affects specific lots contributing to elevated platelet background counts in analyzers. Healthcare providers and patients must stop using this product immediately.

Beckman Coulter
Due to
Read more